MRNA
Moderna, Inc. · Healthcare · Biotechnology
TECHBuyZACKSHold
R500#197 today
$190.01
+0.57% today · -4.46% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- MRNA +0.57% on the last session vs SPY +0.74%: −0.2 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 59 big drops in the past 5 years, MRNA typically lost 3.5% over the next week (median) and was higher only 36% of the time; half the outcomes fell between -8.2% and +7.4%. An ordinary week: -0.3%. Among S&P 500 stocks after big drops, that ranks #466 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 5
Before the open · in 32 days
EPS estimate
−$1.30
−$3.32 to −$0.53 · 15 analysts
Revenue estimate
$894.8M
$827.0M to $1.1B
Track record
7/8 beats
last 8 reports · moved ±4.2% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 BMO | 2Q2026 | −$2.06 | −$1.97 | +$0.09 (+4.3%) beat | $145.0M | -5.3% -6.1 vs SPY | -0.1% | -7.0% |
| Apr 30, 2026 AMC | 1Q2026 | −$3.88 | −$3.40 | +$0.48 (+12.4%) beat | $389.0M | -1.2% -1.5 vs SPY | +1.5% | +5.7% |
| Feb 13, 2026 BMO | 4Q2025 | −$2.60 | −$2.11 | +$0.49 (+18.9%) beat | $678.0M | +5.3% +5.2 vs SPY | +4.3% | +24.3% |
| Nov 6, 2025 BMO | 3Q2025 | −$2.18 | −$0.51 | +$1.67 (+76.6%) beat | $1.0B | +3.3% +4.3 vs SPY | +7.1% | +13.4% |
| Aug 1, 2025 BMO | −$3.00 | −$2.13 | +$0.87 (+29.0%) beat | — | -6.6% -5.0 vs SPY | -6.7% | -10.0% | |
| May 1, 2025 BMO | −$3.11 | −$2.52 | +$0.59 (+19.0%) beat | — | -5.3% -6.0 vs SPY | -3.0% | -15.7% | |
| Feb 14, 2025 BMO | −$2.73 | −$2.91 | −$0.18 (−6.6%) miss | — | +3.4% +3.4 vs SPY | -4.3% | +11.3% | |
| Nov 7, 2024 BMO | −$1.94 | $0.03 | +$1.97 (>+100%) beat | — | -3.0% -3.7 vs SPY | +9.2% | -18.7% | |
| Aug 1, 2024 BMO | −$3.35 | −$3.33 | +$0.02 (+0.6%) beat | — | -21.0% -19.6 vs SPY | -16.5% | -31.6% | |
| May 2, 2024 BMO | −$3.57 | −$3.07 | +$0.50 (+14.0%) beat | — | +12.7% +11.7 vs SPY | +3.0% | +9.4% | |
| Feb 22, 2024 BMO | −$0.99 | $0.55 | +$1.54 (>+100%) beat | — | +13.5% +11.5 vs SPY | +4.9% | +11.3% | |
| Nov 2, 2023 BMO | −$2.05 | −$9.53 | −$7.48 (<−100%) miss | — | -6.5% -8.4 vs SPY | -15.6% | -6.4% | |
| Aug 3, 2023 BMO | −$4.12 | −$3.62 | +$0.50 (+12.1%) beat | — | -0.2% +0.1 vs SPY | -1.4% | -7.6% | |
| May 4, 2023 AMC | −$1.73 | $0.19 | +$1.92 (>+100%) beat | — | +2.0% +0.2 vs SPY | +0.2% | -4.4% | |
| Feb 23, 2023 BMO | $4.60 | $3.61 | −$0.99 (−21.5%) miss | — | -6.7% -7.2 vs SPY | -2.8% | -14.2% | |
| Nov 3, 2022 BMO | $3.11 | $2.53 | −$0.58 (−18.6%) miss | — | -0.8% +0.3 vs SPY | -6.6% | +9.8% | |
| Aug 3, 2022 BMO | $4.49 | $5.24 | +$0.75 (+16.7%) beat | — | +16.0% +14.4 vs SPY | +4.3% | +6.4% | |
| May 4, 2022 BMO | $5.62 | $8.58 | +$2.96 (+52.7%) beat | — | +5.8% +2.8 vs SPY | +4.7% | -9.7% | |
| Feb 24, 2022 BMO | $9.81 | $11.29 | +$1.48 (+15.1%) beat | — | +15.1% +13.6 vs SPY | +3.0% | +8.9% | |
| Nov 4, 2021 BMO | $9.42 | $7.70 | −$1.72 (−18.3%) miss | — | -17.9% -18.4 vs SPY | -14.5% | -33.8% | |
| Aug 5, 2021 BMO | $5.86 | $6.46 | +$0.60 (+10.2%) beat | — | — | — | — | |
| May 6, 2021 BMO | $2.47 | $2.84 | +$0.37 (+15.0%) beat | — | — | — | — | |
| Feb 25, 2021 BMO | −$0.36 | −$0.69 | −$0.33 (−91.7%) miss | — | — | — | — | |
| Oct 29, 2020 BMO | −$0.37 | −$0.59 | −$0.22 (−59.5%) miss | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | −$1.27 (15) | −$3.32 – −$0.53 | -150% | +12.9% | ▲4 ▼0 | $894.8M | -12% |
| Next quarter · Dec 31, 2026 | −$1.75 (14) | −$2.09 – −$0.63 | +17% | -11.5% | ▲5 ▼0 | $668.1M | -1% |
| Current year · Dec 31, 2026 | −$8.39 (21) | −$10.55 – −$6.66 | -16% | -2.8% | ▲7 ▼1 | $2.1B | +8% |
| Next year · Dec 31, 2027 | −$4.79 (20) | −$7.11 – −$2.73 | +43% | +2.2% | ▲6 ▼4 | $2.4B | +16% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.